3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Leukemia, Biphenotypic, Acute
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Leukemia, Myeloid, Accelerated Phase
4
Blast Crisis
4
Down Syndrome
3
Myelodysplastic Syndromes
2
Lymphoma, Mantle-Cell
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Urinary Bladder Neoplasms
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Primary Myelofibrosis
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Mouth Neoplasms
1
Medulloblastoma
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Carcinoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Nivolumab
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
Cisplatin
4
pembrolizumab
3
cabozantinib
3
avelumab
3
Ipilimumab
3
Carboplatin
3
CTLA-4 Antigen
3
enfortumab vedotin
2
Immunoglobulin G
2
Disulfides
2
Biopsy
2
tremelimumab
1
trastuzumab deruxtecan
1
tocilizumab
1
tamibarotene
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
atezolizumab
1
Propranolol
1
Platinum
1
Leucovorin
1
Lenalidomide
1
Fluorouracil
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urethral Neoplasms
×
merphos
×
1 year
×
Clear all
No trials found.